RxDoctor Payments Data

Alireza Namini, MD

Neuroradiology · van Nuys, CANPI 1124331095

Payments from drug & device makers

$121in general payments, 2019–2025

Across 1 payment — averaging $120.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$121

What the payments were for

  • Food & beverage$121100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim1$121

How this compares

$121 in reported general payments places this provider in the 25th percentile of 154 neuroradiology providers in California.

See all neuroradiology providers in California

Medicare billing

Part B allowed, 2024
$872,527
Medicare patients
3,669
Services billed
63,492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$10,889

Paid to pharmacies, not to this prescriber.

Other neuroradiology in van Nuys

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →